trending Market Intelligence /marketintelligence/en/news-insights/trending/uccgmBdW3vDdL4elS0-ZwA2 content esgSubNav
In This List

Loxo Oncology names chief development officer, COO

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Loxo Oncology names chief development officer, COO

Loxo Oncology Inc. promoted Nisha Nanda to the post of chief development officer and changed Jacob Van Naarden's title to COO, effective Jan. 2.

Nanda previously worked as senior vice president of development strategy from January 2017 to December 2018 at the Stamford, Conn.-based cancer drug developer.

Van Naarden was chief business officer at Loxo from January 2016 to December 2018 and vice president of corporate development and strategy from May 2014 to December 2015.